A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapy

Abstract Background Non-communicable chronic diseases are characterized by low-grade inflammation and oxidative stress. Extensive research has identified the transcription factor NRF2 as a potential therapeutic target. Current NRF2 activators, designed to inhibit its repressor KEAP1, often exhibit u...

Full description

Saved in:
Bibliographic Details
Main Authors: Ángel J. García-Yagüe, Lucía Cañizares-Moscato, José Antonio Encinar, Eduardo Cazalla, Raquel Fernández-Ginés, Maribel Escoll, Ana I. Rojo, Antonio Cuadrado
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Biomedical Science
Subjects:
Online Access:https://doi.org/10.1186/s12929-025-01157-3
Tags: Add Tag
No Tags, Be the first to tag this record!